Institutional investors purchased a net $3.9 million shares of BTX during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 46.50% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BROADWOOD CAPITAL, INC. Bought 2.7 Million shares of BioTime Inc
THE VANGUARD GROUP, INC. Bought 408.9 Thousand shares of BioTime Inc
GREENWAY PARTNERS LP Bought 300.0 Thousand shares of BioTime Inc